机译：系统评价和荟萃分析的转载首选报告项目：PRISMA声明
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G. Altman, and the PRISMA GroupD. Moher, PhD, Ottawa Methods Centre, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, Critical Care Wing (Eye Institute), 6th Floor, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada, e-mail, dmoher@ohri.ca.A. Liberati, MD, DrPH, Universita` di Modena e Reggio Emilia and Centro Cochrane Italiano, Istituto Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156 Milan, Italy.J. Tetzlaff, BSc, Ottawa Methods Centre, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, Critical Care Wing (Eye Institute), 6th Floor, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada.D.G. Altman, DSc, Centre for Statistics in Medicine, University of Oxford, Wolfson College Annexe, Linton Road, Oxford OX2 6UD, United Kingdom.[Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med. Jul 2009. Available at: http://www.annals.org/cgi/content/full/151/4/264.]© 2009 American Physical Therapy AssociationAuthor and Article Information: The following people contributed to the PRISMA Statement: Doug Altman, DSc, Centre for Statistics in Medicine (Oxford, United Kingdom), Gerd Antes, PhD, University Hospital Freiburg (Freiburg, Germany), David Atkins, MD, MPH, Health Services Research & Development Service, Veterans Health Administration (Washington, DC), Virginia Barbour, MRCP, DPhil, PLoS Medicine (Cambridge, United Kingdom), Nick Barrowman, PhD, Children's Hospital of Eastern Ontario (Ottawa, Ontario, Canada), Jesse A. Berlin, ScD, Johnson & Johnson Pharmaceutical Research and Development (Titusville, New Jersey), Jocalyn Clark, PhD, PLoS Medicine (at the time of writing, BMJ, London, United Kingdom), Mike Clarke, PhD, UK Cochrane Centre (Oxford, United Kingdom) and School of Nursing and Midwifery, Trinity College (Dublin, Ireland), Deborah Cook, MD, Departments of Medicine, Clinical Epidemiology and Biostatistics, McMaster University (Hamilton, Ontario, Canada), Roberto D'Amico, PhD, Universita` di Modena e Reggio Emilia (Modena, Italy) and Centro Cochrane Italiano, Istituto Ricerche Farmacologiche Mario Negri (Milan, Italy), Jonathan J. Deeks, PhD, University of Birmingham (Birmingham, United Kingdom), P.J. Devereaux, MD, PhD, Departments of Medicine, Clinical Epidemiology and Biostatistics, McMaster University (Hamilton, Ontario, Canada), Kay Dickersin, PhD, Johns Hopkins Bloomberg School of Public Health (Baltimore, Maryland), Matthias Egger, MD, Department of Social and Preventive Medicine, University of Bern (Bern, Switzerland), Edzard Ernst, MD, PhD, FRCP, FRCP(Edin), Peninsula Medical School (Exeter, United Kingdom), Peter C. Gøtzsche, MD, MSc, The Nordic Cochrane Centre (Copenhagen, Denmark), Jeremy Grimshaw, MBChB, PhD, FRCFP, Ottawa Hospital Research Institute (Ottawa, Ontario, Canada), Gordon Guyatt, MD, Departments of Medicine, Clinical Epidemiology and Biostatistics, McMaster University (Hamilton, Ontario, Canada), Julian Higgins, PhD, MRC Biostatistics Unit (Cambridge, United Kingdom), John P.A. Ioannidis, MD, University of Ioannina Campus (Ioannina, Greece), Jos Kleijnen, MD, PhD, Kleijnen Systematic Reviews Ltd (York, United Kingdom) and School for Public Health and Primary Care (CAPHRI), University of Maastricht (Maastricht, the Netherlands), Tom Lang, MA, Tom Lang Communications and Training (Davis, California), Alessandro Liberati, MD, Universita` di Modena e Reggio Emilia (Modena, Italy) and Centro Cochrane Italiano, Istituto Ricerche Farmacologiche Mario Negri (Milan, Italy), Nicola Magrini, MD, NHS Centre for the Evaluation of the Effectiveness of Health Care-CeVEAS (Modena, Italy), David McNamee, PhD, The Lancet (London, United Kingdom), Lorenzo Moja, MD, MSc, Centro Cochrane Italiano, Istituto Ricerche Farmacologiche Mario Negri (Milan, Italy), David Moher, PhD, Ottawa Methods Centre, Ottawa Hospital Research Institute (Ottawa, Ontario, Canada), Cynthia Mulrow, MD, MSc, Annals of Internal Medicine (Philadelphia, Pennsylvania), Maryann Napoli, Center for Medical Consumers (New York, New York), Andy Oxman, MD, Norwegian Health Services Research Centre (Oslo, Norway), Ba' Pham, MMath, Toronto Health Economics and Technology Assessment Collaborative (Toronto, Ontario, Canada, at the time of the first meeting of the group, GlaxoSmith- Kline Canada [Mississauga, Ontario, Canada]), Drummond Rennie, MD, FRCP, FACP, University of California, San Francisco (San Francisco, California), Margaret Sampson, MLIS, Children's Hospital of Eastern Ontario (Ottawa, Ontario, Canada), Kenneth F. Schulz, PhD, MBA, Family Health International (Durham, North Carolina), Paul G. Shekelle, MD, PhD, Southern California Evidence-Based Practice Center (Santa Monica, California), Jennifer Tetzlaff, BSc, Ottawa Methods Centre, Ottawa Hospital Research Institute (Ottawa, Ontario, Canada), David Tovey, FRCGP, The Cochrane Library, Cochrane Collaboration (Oxford, United Kingdom, at the time of the first meeting of the group, BMJ [London, United Kingdom]), and Peter Tugwell, MD, MSc, FRCPC, Institute of Population Health, University of Ottawa (Ottawa, Ontario, Canada).Grant Support: PRISMA was funded by the Canadian Institutes of Health Research, Universita` di Modena e Reggio Emilia, Italy, Cancer Research UK, Clinical Evidence BMJ Knowledge, The Cochrane Collaboration, and GlaxoSmithKline, Canada. Dr. Liberati is funded, in part, through grants of the Italian Ministry of University (COFIN-PRIN 2002 prot. 2002061749 and COFIN-PRIN 2006 prot. 2006062298). Dr. Altman is funded by Cancer Research UK. Dr. Moher is funded by a University of Ottawa Research Chair. None of the sponsors had any involvement in the planning, execution, or write-up of the PRISMA documents. Additionally, no funder played a role in drafting the manuscript.Potential Financial Conflicts of Interest: None disclosed.,;
机译：评估系统评价和荟萃分析（PRISMA）陈述及扩展的首选报告项目的使用和影响：范围界定审查
机译：系统评价和荟萃分析（PRISMA）陈述和发表偏见的首选报告项目。
机译：系统评价和荟萃分析的首选报告项目：PRISMA声明
机译：针灸师的教育和培训会影响系统评价和荟萃分析的结果
机译：阿育吠陀干预对高胆固醇血症，高血压和冠心病的影响的系统评价和荟萃分析
机译：评价首选报告项目的系统评价和荟萃分析（PRISMA）对已发表的系统评价和荟萃分析质量的认可
机译：图1：系统评价和荟萃分析的首选报告项目（prisma）流程图（http://www.prisma-statement.org）。
